The prevalence of multiple sclerosis in the world: an update
By G. Rosati. Neurological Sciences, 2001
737 citations recorded by the source corpus.
Subfields: Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/3763a2df8c0c5800fa95085a41b725b9ea1763cd
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pathology and Forensic Medicine
- Jorge R. Oksenberg
- Ron Milo
- Lauren B. Krupp
- Stephen L. Hauser
- E. Kahana
- D. Abernethy
- Richard J. Siegert
Citations in the corpus
- The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. (2006, background): “The disease is uncommon among Samis, Turkmen, Uzbeks, Kazakhs, Kyrgyzis, native Siberians, North and South Amerindians, Chinese, Japanese, African blacks, and New Zealand Maori (Rosati, 2001).”
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis (2010, background): “The prevalence is greatest in Caucasians, with high prevalence rates reported in Europe, Canada, USA, Australia, New Zealand and northern Asi”
- Fatigue in Multiple Sclerosis (2003, background): “[1] This immune-mediated disorder targets the central nervous system and is marked by demye-”
- Multiple sclerosis: geoepidemiology, genetics and the environment. (2010, background): “1, Table 1) [1,2].”